Medmira Stock Today
| MIR Stock | CAD 0.13 0.01 7.14% |
Performance12 of 100
| Odds Of DistressLess than 41
|
MedMira is selling for under 0.13 as of the 31st of January 2025; that is 7.14 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.13. MedMira has about a 41 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 31st of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America and the Caribbean, Europe, the Asia Pacific, and internationally. The company was founded in 1993 and is headquartered in Halifax, Canada. The company has 701.73 M outstanding shares of which 979 shares are now shorted by private and institutional investors with about 0.02 days to cover all short positions. More on MedMira
Moving against MedMira Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
MedMira Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. MedMira's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding MedMira or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Hermes Chan | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
MedMira's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to MedMira's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsMedMira can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand MedMira's financial leverage. It provides some insight into what part of MedMira's total assets is financed by creditors.
| |||||
MedMira (MIR) is traded on TSX Venture Exchange in Canada and employs 5 people. MedMira is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 56.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MedMira's market, we take the total number of its shares issued and multiply it by MedMira's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. MedMira classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 701.73 M outstanding shares of which 979 shares are now shorted by private and institutional investors with about 0.02 days to cover all short positions.
MedMira has accumulated about 1.06 K in cash with (2.94 M) of positive cash flow from operations.
Check MedMira Probability Of Bankruptcy
Ownership AllocationMedMira maintains a total of 701.73 Million outstanding shares. MedMira secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.95 % of MedMira outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check MedMira Ownership Details
MedMira Risk Profiles
Although MedMira's alpha and beta are two of the key measurements used to evaluate MedMira's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.1 | |||
| Semi Deviation | 4.25 | |||
| Standard Deviation | 6.19 | |||
| Variance | 38.35 |
MedMira Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in MedMira without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Additional Tools for MedMira Stock Analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.